Medindia LOGIN REGISTER
Medindia
Advertisement

Manchester Announces Availability of Chenodal(TM)

Tuesday, December 15, 2009 Drug News
Advertisement


FORT COLLINS, Colo., Dec. 14 Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an important therapy for patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age.
Advertisement

Chenodal prescriptions have started to be dispensed to patients exclusively through Centric Health Resources ("Centric"), a specialty pharmacy company. Centric provides a single point of contact to deliver seamless support for Chenodal including providing necessary information to health care providers, patients and families, assisting with reimbursement and insurance issues, and ensuring that Chenodal reaches the patients who need it as fast and as conveniently as possible. Patients and physicians are encouraged to contact Centric now at 1-866-758-7068 to begin the process of setting up their first order of Chenodal or to obtain more information about Chenodal. Centric Customer Service is available Monday through Friday 7:00 AM to 6:00 PM CST.
Advertisement

"The commercial availability of Chenodal now provides doctors and their patients with a chenodiol product that meets all FDA requirements for product integrity, quality, safety and effectiveness," commented Lloyd Glenn, Manchester's President.

About Manchester:

Manchester Pharmaceuticals, a privately-held specialty pharmaceutical company, is focused on the identification, development and commercialization of new therapeutic modalities to address the special needs of patients with rare diseases. Manchester is actively pursuing the license and acquisition of additional new product opportunities in the rare disease area.

For more information: Lloyd Glenn, President 970-685-4119 www.manchesterpharma.com

SOURCE Manchester Pharmaceuticals, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close